Patent · US Active

Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections

US8796303B2 · kind B2 · utility

0Cited by

22References

24Claims

0Family size

Assignee

BIOTA SCIENTIFIC MANAGEMENT PTY LTD · AU

Inventors

Penelope Anne Mayes · Melbourne, AU
Jeffrey Peter Mitchell · Melbourne, AU
Alistair George Draffan · Melbourne, AU
Gary Robert William Pitt · Melbourne, AU
Kelly Helen Anderson · Melbourne, AU
Chin Yu Lim · Clayton, AU

Key dates

Filing date	Nov 22, 2011
Grant date	Aug 5, 2014
Priority date	—
Expiry date	Nov 22, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I), racemates, isomers and/or salts thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.